Identification of trans-eQTLs has been limited by a heavy multiple testing burden, read-mapping biases, and hidden confounders. To address these issues, we developed GBAT, a powerful genebased method that allows robust detection of trans gene regulation. Using simulated and real data, we show that GBAT drastically increases detection of trans-gene regulation over standard trans-eQTL analyses.
. Schematic of the GBAT pipeline. First, GBAT discards reads that are mapped to homologous sequences in the genome in order to prevent false positives in trans association mapping. Discarded reads include multi-mapped reads and reads that are mapped to regions of low mappability. After expression quantification, GBAT predicts the the expression levels from cis genetic variants (cross-validated cisgenetic prediction of gene i (CVGP i )) using cvBLUP. Finally, GBAT performs gene-based association tests between CVGP i and expression level of gene j to identify gene-based trans association, while properly including supervised surrogate variables conditional on each CVGP i (SV i ) as covariates.
Finally, we test the association of each CVGP i with quantile normalized expression levels E j of every trans gene j (at least 1Mb away from gene i). Cis-eQTL studies typically include covariates such as PEER factors or surrogate variables from SVA that are intended to model confounders 17, 18 . To prevent false positives 13 and power loss in trans-eQTL studies 11, 12 , the use of supervised versions of PEER and SVA is recommended 13 . Therefore, for each CVGP i , we run supervised SVA conditional on CVGP i , such that the resulting surrogate variables SV i does not include the genetic effects of gene i. We then use SV i as covariates. While including conditional SVs as covariate is computationally efficient in our gene-based approach, it is impossible in SNP based trans association testing.
In addition, GBAT regresses E j on SV i and uses the quantile normalized residuals E j ' for genebased testing using the regression: E j '~ CVGP i . We found that the p-values from this test are well calibrated (Supplementary Notes, Figure S2 ). However, skipping the normalization caused false positive inflation, as did using the models:
the naïve SVA not conditioning on CVGP i ) ( Figure S2 ).
Using real genotypes from a whole blood RNA-seq dataset: the Depression Genes and Networks cohort 9 (DGN, sample size N=913), we performed simulations to assess the power of our genebased approach (GBAT) in comparison to a SNP-based approach (Methods). We simulated a causal SNPècis-expressionètrans-expression model with realistic effect-sizes under different genetic architectures (proportion of causal SNPs = 0.1%, 1% and 10%) and sample sizes (N=200,400,600 and 913) (Supplementary Notes). To better reflect the imperfect genotyping of the individuals, we assumed that only 10% of the SNPs are genotyped, such that not all causal SNPs are observed. We measured the power of both approaches to identify significant trans associations (accounting for 1 million×15000 SNP-gene pairs for SNP-based approach or 5,000
×15,000 (highly heritable gene)-gene pairs for the GBAT approach, using Bonferroni correction). Across all simulated genetic architectures of gene expression and combinations of cis-and trans-effects, we observed that the power of the GBAT approach is substantially higher than the SNP-based method (Figure 2a , Figure S3 ).
We next applied GBAT to the DGN dataset to detect trans-gene regulation signal for real expression phenotypes. We built cross-validated cis-genetic (CVGP) expression levels using cvBLUP with variants within 100kb of the transcription start site. Prediction accuracy was assessed using squared correlation (prediction R 2 ) between observed and predicted expression levels. On average across all genes, the prediction R 2 is 85% of the cis SNP heritability (ℎ ! ! ) estimated by restricted maximum likelihood (REML) ( Figure 2b ). We note our prediction accuracy is comparable to prediction methods modeling the sparse genetic architecture of cisgene regulations (Figure 3 of ref 18 and Figure 4 of ref 19 ). After gene-based association test, we Table S2 ). Both regulators and trans target genes show heritability enrichment in autoimmune diseases, including lupus, ulcerative colitis, Crohn's disease and inflammatory bowel disease ( Figure S4 ), by using stratified LDSC 22 .
Among 157 unique trans regulators, 20 were found to regulate more than 3 genes (Table S4) Remarkably, we found that 19 SRCAP target genes (out of 88 genes, 2.9 fold enrichment, Fisher's test) overlap with genes associated with blood cell type proportions (Table S5 ) from the GWAS catalog (see URLs). Our discovery highlights the gene co-expression network driven by SRCAP (Figure 2e ) is relevant to haematopoiesis and immune cell type proportions, and suggests that SRCAP is a master regulator that controls lineage commitment during haematopoiesis.
GBAT was carefully designed to improve power and reduce false positives in detecting trans signals; failing to properly perform the recommended steps led to an increase in false positives or loss of power. For example, incomplete removal of problematic sequence reads resulted in 220% more trans signals, most of which are likely to be false positives; correcting for covariates using regression model E j ~ CVGP i + SV i resulted in 39% more trans signals, also likely due to false positives inflation (Supplementary notes).
GBAT can be used to detect other trans gene regulatory events, such as splicing, methylation, protein regulation or gene network response to stimulus. As larger studies become available for increasingly diverse populations, tissues, and functional genomic measurements, we foresee more trans regulation discoveries will reveal new disease genes and mechanisms.
Methods

Cross-validated cis-genetic prediction with cvBLUP.
The cross-validated prediction by cvBLUP is a cross validated version of a standard linear mixed model (LMM) prediction, or best linear unbiased predictor (BLUP). We consider an LMM as below:
where y is the phenotype, in particular the expression of gene, measured on N individuals. X is a matrix of covariates, including an intercept. Z is a standardized N×M matrix of M SNPs within the cis region of the gene. b is the vector of effect sizes for the SNPs in Z, modeled as normally distributed by ~(0, 
are the phenotypic residuals after removing the contributions of the covariates X.
The standard BLUPs, !"#$ , over-fit the training data, meaning that they are highly correlated with the noise term . Cross-validation is often used to mitigate overfitting. In our analysis, we use a leave-one-out cross-validation scheme to generate a set of out-of-sample LMM predictions:
each subject is left out of the dataset in turn; the remaining subjects are used to estimates , and then the genetic contribution to the left-out subject's phenotype is defined using .
The resulting collection of cross-validated LMM estimates, or cvBLUPs, is still a strong estimator of the true cis-genetic contribution to the phenotype, but does not have spurious correlations with . Fortunately, leave-one-out cross-validation is mathematically simple for BLUPs. Given !"#$ = ! ! !! = , such that the prediction is a linear operator = ! ! !! applied to , the out-of-sample prediction and prediction errors can be simply calculated from a single model fit. The cvBLUPs can therefore be calculated in linear time as:
For any gene i, the cross validated cis-genetic prediction value (CVGP i ) is calculated with all cis genetic variants (±100kb to transcription starting sites) of gene i by using Equation (2).
Gene-based association testing of trans signals (GBAT)
For any gene i, we test the gene-based trans association between CVGP i and the expression level of gene j (E j ). Gene j is in trans to gene i if it is at least 1Mb away from gene i. To improve association power and reduce spurious trans association signal, we used supervised SVA conditioning on CVGP i (SV i ) as covariates 11, 14, 24 . We first regressed out SV i from quantile normalized expression E j in a linear model E j ~ SV i . Then we used the quantile normalized residuals E j ' to test for trans association: E j '~ CVGP i .
To compute the FDR levels from all trans association tests, we used only the summary association p-values from the inter-chromosomal trans association tests. We used 10% FDR for significant trans signals. We further removed gene pairs that are cross mappable due to sequence similarities surrounding the gene pairs 25 .
URLs
GBAT: the pipeline will be available before publication PLINK 2.0: https://www. 
